Found: 8
Select item for more details and to access through your institution.
B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren’s Syndrome.
- Published in:
- Scandinavian Journal of Immunology, 2008, v. 67, n. 2, p. 185, doi. 10.1111/j.1365-3083.2007.02049.x
- By:
- Publication type:
- Article
Focal myositis with fasciitis and vasculitis revealing chronic lymphocytic leukaemia.
- Published in:
- Rheumatology, 2005, v. 44, n. 10, p. 1324, doi. 10.1093/rheumatology/keh706
- By:
- Publication type:
- Article
Is Inhibitor of differentiation 3 involved in human primary Sjogrens syndrome?
- Published in:
- Rheumatology, 2008, v. 47, n. 4, p. 437, doi. 10.1093/rheumatology/ken013
- By:
- Publication type:
- Article
银屑病患者的述情障碍逆转.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 2, p. e61, doi. 10.1111/bjd.17492
- By:
- Publication type:
- Article
Alexithymia reversion in psoriasis.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 2, p. e48, doi. 10.1111/bjd.17479
- By:
- Publication type:
- Article
Reversibility of alexithymia with effective treatment of moderate‐to‐severe psoriasis: longitudinal data from EPIDEPSO.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 2, p. 397, doi. 10.1111/bjd.17259
- By:
- Publication type:
- Article
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.
- Published in:
- British Journal of Dermatology, 2017, v. 176, n. 5, p. 1195, doi. 10.1111/bjd.15243
- By:
- Publication type:
- Article
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial ( TRANSIT).
- Published in:
- British Journal of Dermatology, 2014, v. 170, n. 2, p. 425, doi. 10.1111/bjd.12646
- By:
- Publication type:
- Article